GlassScriptPhysician profile
Sara E Wertman
NPI 1770704439
$1,789.91
in general payments reported to CMS, 2019-2025
37 companies · $436 in 2025
The $436 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $414 · 2023: $469 · 2024: $471 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,375.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $195.89 | 2022-2024 | Briviact, Rystiggo |
| Abbvie INC. | $163.44 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $111.12 | 2023-2025 | Rexulti, Nuedexta |
| Mdd US Operations, LLC | $105.73 | 2023-2025 | Gocovri, Gocovri |
| Lundbeck LLC | $89.67 | 2022-2023 | Vyepti |
| Alexion Pharmaceuticals, INC. | $84.21 | 2022-2025 | Ultomiris |
| Jazz Pharmaceuticals INC. | $80.93 | 2022-2024 | |
| Alnylam Pharmaceuticals INC. | $73.50 | 2024-2025 | Onpattro |
| Eisai INC. | $71.15 | 2022-2024 | |
| Upsher-Smith Laboratories LLC | $60.23 | 2022-2023 | |
| Corium, LLC | $60.17 | 2022-2023 | Adlarity, Adlarity |
| Biohaven Pharmaceutical Holding Company LTD. | $57.89 | 2022 | |
| Neurelis, INC. | $55.07 | 2023-2025 | Valtoco |
| Sk Life Science, INC. | $38.70 | 2023-2024 | |
| Ge Healthcare | $38.27 | 2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $37.19 | 2024 | Vyvgart, Vyvgart Hytrulo |
| Emd Serono, INC. | $34.47 | 2022-2023 | Mavenclad |
| Aucta Pharmaceuticals, INC. | $34.11 | 2025 | Motpoly Xr |
| Impel Pharmaceuticals INC. | $31.92 | 2023 | Trudhesa |
| Genzyme Corporation | $31.12 | 2025 | |
| C2n Diagnostics, LLC | $24.71 | 2025 | Precivityad2 |
| Banner Life Sciences, LLC | $24.60 | 2023 | |
| Ani Pharmaceuticals, INC. | $22.72 | 2022 | |
| Tg Therapeutics, INC. | $21.65 | 2023 | |
| Lilly USA, LLC | $21.51 | 2024 | |
| Acadia Pharmaceuticals INC | $21.28 | 2025 | Daybue |
| Catalyst Pharmaceuticals, INC. | $21.27 | 2023 | Firdapse |
| Kedrion Biopharma, INC. | $20.80 | 2025 | Rhogam Ultra-Filtered Plus, Koate, Gammaked |
| Pfizer INC. | $20.49 | 2024 | |
| Biogen, INC. | $19.18 | 2025 | Spinraza, Qalsody |
| Abbott Laboratories | $18.69 | 2025 | Infinity |
| Teva Pharmaceuticals USA, INC. | $18.53 | 2022 | |
| Collegium Pharmaceutical, INC. | $18.18 | 2022 | |
| Mallinckrodt Hospital Products INC. | $17.49 | 2022 | |
| Genentech USA, INC. | $15.19 | 2025 | Ocrevus Zunovo |
| Avion Pharmaceuticals | $15.07 | 2022 | |
| Janssen Biotech, INC. | $13.77 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Wertman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.